Ascletis Pharma Inc. (ASCLF)
OTCMKTS
· Delayed Price · Currency is USD
0.8478
+0.0334 (4.10%)
At close: May 9, 2025
Ascletis Pharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -300.94 | -144.72 | -314.84 | -199.02 | -209.24 | Upgrade
|
| Depreciation & Amortization | 18.86 | 16.78 | 28.4 | 27.83 | 25.77 | Upgrade
|
| Other Amortization | 1.89 | 3.42 | 2.11 | 2.14 | 1.84 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.34 | -0.09 | 0 | - | 0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | 10.58 | - | 55.19 | - | 5.77 | Upgrade
|
| Loss (Gain) From Sale of Investments | 25.25 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | -15.87 | -40.31 | 22.89 | 17.88 | 13.75 | Upgrade
|
| Stock-Based Compensation | 3 | 1.33 | 3.19 | 7.13 | 4.61 | Upgrade
|
| Provision & Write-off of Bad Debts | -0 | -0 | -0.01 | 0.01 | -0.08 | Upgrade
|
| Other Operating Activities | -98.48 | -94.67 | -33.2 | 7.27 | 62.07 | Upgrade
|
| Change in Accounts Receivable | 5.28 | 18.44 | 29.74 | -26.99 | 42.98 | Upgrade
|
| Change in Inventory | -3.6 | -8.05 | -12.84 | -5.07 | -18.37 | Upgrade
|
| Change in Accounts Payable | -0.62 | -2.49 | 2.08 | 0.12 | -5.71 | Upgrade
|
| Change in Unearned Revenue | -1.59 | -1.59 | -1.59 | -2.61 | -1.72 | Upgrade
|
| Change in Other Net Operating Assets | 14.31 | 28.14 | 16.41 | 24.37 | -6.67 | Upgrade
|
| Operating Cash Flow | -341.58 | -223.8 | -202.46 | -146.93 | -84.91 | Upgrade
|
| Capital Expenditures | -2.1 | -6.21 | -7.07 | -4.97 | -4.92 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.12 | - | - | 0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.05 | -12.95 | -7.24 | -2.23 | -34.04 | Upgrade
|
| Investment in Securities | 853.84 | 160.73 | -1,137 | -269.78 | 170.96 | Upgrade
|
| Other Investing Activities | 127.22 | 87.78 | 3.32 | 2.48 | 0.29 | Upgrade
|
| Investing Cash Flow | 978.91 | 229.48 | -1,148 | -274.49 | 132.3 | Upgrade
|
| Long-Term Debt Repaid | -4.73 | -2.39 | -2.22 | -2.28 | -1.93 | Upgrade
|
| Net Debt Issued (Repaid) | -4.73 | -2.39 | -2.22 | -2.28 | -1.93 | Upgrade
|
| Issuance of Common Stock | - | - | 0.96 | - | - | Upgrade
|
| Repurchase of Common Stock | -98.53 | -78.96 | - | -28.69 | -19.6 | Upgrade
|
| Other Financing Activities | -0.24 | -0.14 | -0.16 | -0.13 | -0.14 | Upgrade
|
| Financing Cash Flow | -103.51 | -81.5 | -1.42 | -31.1 | -21.67 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.39 | 2.16 | 28.62 | -30.57 | -110.26 | Upgrade
|
| Net Cash Flow | 534.21 | -73.65 | -1,324 | -483.09 | -84.54 | Upgrade
|
| Free Cash Flow | -343.67 | -230.01 | -209.53 | -151.9 | -89.83 | Upgrade
|
| Free Cash Flow Margin | -26786.75% | -406.40% | -387.38% | -197.59% | -256.66% | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.21 | -0.19 | -0.14 | -0.09 | Upgrade
|
| Cash Interest Paid | 0.24 | 0.14 | 0.16 | 0.13 | 0.14 | Upgrade
|
| Levered Free Cash Flow | -208.35 | -131.07 | -114.01 | -111.93 | -90.34 | Upgrade
|
| Unlevered Free Cash Flow | -208.2 | -130.98 | -113.91 | -111.86 | -90.26 | Upgrade
|
| Change in Net Working Capital | -23.09 | -59.73 | -84.59 | -2.28 | -72.06 | Upgrade
|
Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.